FDA approves Bosulif to treat CML
The U.S. Food and Drug Administration (FDA) announced last week the approval of Pfizer’s Bosulif, a drug to treat the blood and bone marrow disease, chronic myelogenous leukemia (CML). Bosulif (bosutinib) is More...